Evidence map›Paper›PMID 37141283›Full record

ArticleBrain : a journal of neurology2023

Deep brain stimulation alleviates tics in Tourette syndrome via striatal dopamine transmission.

Aaron E Rusheen, Juan Rojas-Cabrera, Abhinav Goyal, Hojin Shin, Jason Yuen, Dong-Pyo Jang, Keven E Bennet, Charles D Blaha, Kendall H Lee, Yoonbae Oh

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Neuromodulation of the central nervous system for facial pain.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Optimal Deep Brain Stimulation Locations for Gilles de la Tourette Syndrome.medRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Science advances · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Deep brain stimulation for Tourette's syndrome.The Cochrane database of systematic reviews · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Aaron E RusheenMedical Scientist Training Program, Mayo Clinic, Rochester, MN 55902, USA.ORCID 0000-0001-8029-1167
Juan Rojas-CabreraMedical Scientist Training Program, Mayo Clinic, Rochester, MN 55902, USA.
Abhinav GoyalMedical Scientist Training Program, Mayo Clinic, Rochester, MN 55902, USA.
Hojin ShinDepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN 55902, USA.
Jason YuenDepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN 55902, USA.
Dong-Pyo JangDepartment of Biomedical Engineering, Hanyang University, Seoul 04763, South Korea.
Keven E BennetDepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN 55902, USA.
Charles D BlahaDepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN 55902, USA.
Kendall H LeeDepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN 55902, USA.
Yoonbae OhDepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN 55902, USA.
Mayo Clinic · USBarwon Health · AUHanyang University · KRMayo Clinic in Florida · US

Funding

TRAINING IN TRANSLATIONAL RESEARCH: BENCH TO BEDSIDER25GM055252 · NIGMS · MAYO CLINIC ROCHESTER · PI LUJAN, LUIS, MAHER, LOUIS JAMES · 1996 to 2022
$8.3M
NRSA Training CoreTL1TR002380 · NCATS · MAYO CLINIC ROCHESTER · PI Felicity T. B. Enders, ANTHONY John WINDEBANK · 2017 to 2026
$6.0M
Medical Scientist Traning Program at Mayo ClinicT32GM065841 · NIGMS · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, SCHIMMENTI, LISA A · 2003 to 2022
$5.8M
An Integrated Neurochemical/Electrophysiological Recording and Neuromodulation System for Basic and Clinical ResearchR42NS125895 · NINDS · WINCS INTERNATIONAL, LLC · PI Kevin Elliott Bennet, Kendall Lee · 2022 to 2026
$2.3M
Development of an innovative in vivo voltammetric technique for measurements of tonic serotonin concentrations in the mammalian brain.R01NS129549 · NINDS · MAYO CLINIC ROCHESTER · PI Kendall H. Lee, Yoonbae Oh · 2023 to 2026
$2.3M
Development of advanced voltammetric method for basal neurotransmitter level measurementR01NS112176 · NINDS · MAYO CLINIC ROCHESTER · PI LEE, KENDALL H., OH, YOONBAE · 2019 to 2022
$1.4M
Mechanism of CMPf Deep Brain Stimulation for Tourette SyndromeF31NS115202 · NINDS · MAYO CLINIC ROCHESTER · PI RUSHEEN, AARON ELLIOTT · 2020 to 2023
$195k
NCATS NIH HHS TL1 TR002380NIGMS NIH HHS T32 GM065841NINDS NIH HHS F31 NS115202
6 · The paper itself

Abstract

Tourette syndrome is a childhood-onset neuropsychiatric disorder characterized by intrusive motor and vocal tics that can lead to self-injury and deleterious mental health complications. While dysfunction in striatal dopamine neurotransmission has been proposed to underlie tic behaviour, evidence is scarce and inconclusive. Deep brain stimulation (DBS) of the thalamic centromedian parafascicular complex (CMPf), an approved surgical interventive treatment for medical refractory Tourette syndrome, may reduce tics by affecting striatal dopamine release. Here, we use electrophysiology, electrochemistry, optogenetics, pharmacological treatments and behavioural measurements to mechanistically examine how thalamic DBS modulates synaptic and tonic dopamine activity in the dorsomedial striatum. Previous studies demonstrated focal disruption of GABAergic transmission in the dorsolateral striatum of rats led to repetitive motor tics recapitulating the major symptom of Tourette syndrome. We employed this model under light anaesthesia and found CMPf DBS evoked synaptic dopamine release and elevated tonic dopamine levels via striatal cholinergic interneurons while concomitantly reducing motor tic behaviour. The improvement in tic behaviour was found to be mediated by D2 receptor activation as blocking this receptor prevented the therapeutic response. Our results demonstrate that release of striatal dopamine mediates the therapeutic effects of CMPf DBS and points to striatal dopamine dysfunction as a driver for motor tics in the pathoneurophysiology of Tourette syndrome.

Indexed as

Deep Brain StimulationTicsTourette SyndromeAnimalsChildDopamineHumansRatsThalamusDopamineDBSdopamineelectrochemistryelectrophysiologyTourette syndrome

Identifiers

PMID37141283
PMCPMC10545518
OpenAlexW4368352593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.